Skip to main content
logo
Alkermes plc (ALKS)
NASDAQ: ALKS · Real-Time Price · USD
28.52
+0.03 (0.11%)
At close: Dec 24, 2025

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202003 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2003 - 2019
Medicines - Product
1.08B
Log In
Log In
Log In
Log In
Upgrade
Medicines - Product Growth
17.78%
Log In
Log In
Log In
Log In
Upgrade
Manufacturing and Royalty
474.10M
Log In
Log In
Log In
Log In
Upgrade
Manufacturing and Royalty Growth
-36.23%
Log In
Log In
Log In
Log In
Upgrade
Research and Development
3.00K
Log In
Log In
Log In
Log In
Upgrade
Research and Development Growth
-84.21%
Log In
Log In
Log In
Log In
Upgrade
License
-
Log In
Log In
Log In
Log In
Upgrade
License Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202003 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2003 - 2019
United States
1.41B
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-5.48%
Log In
Log In
Log In
Log In
Upgrade
Rest of World
146.18M
Log In
Log In
Log In
Log In
Upgrade
Rest of World Growth
-14.16%
Log In
Log In
Log In
Log In
Upgrade
Ireland
1.29M
Log In
Log In
Log In
Log In
Upgrade
Ireland Growth
9.75%
Log In
Log In
Log In
Log In
Upgrade